"This monograph presents the results of a national survey on hepatitis C virus (HCV) infection in corrections in the U.S. This survey looked at both the current and future management of HCV infected patients in the nation’s correctional systems … The survey questions were designed to address six key areas to better understand how HCV infection is managed in corrections. These areas included policy/clinical guidelines, prevalence, current treatment practices, prevention/education strategies, the cost of current treatment and the estimated future cost of treatment using new medications that have recently become available. The findings are presented along with recommendations drawn from those findings that offer guidance to correctional systems as they move forward in treating HCV infection" (p. 1). Sections following an executive summary include: introduction; background; the CCHA (Coalition of Correctional Health Authorities) Hepatitis C Survey; results for the burden of HCV infection in prisons and jails—screening, prevalence, measures of true prevalence, diagnosed prevalence, other prevalence information, case burden, HCV treatment guidelines, patient selection criteria, patient education and substance abuse disorder treatment, current treatment costs, and estimated future costs; discussion--prevalence of HCV infection in corrections, treatment of HCV infection in corrections, and substance use and other prevention; and six recommendations. Some of the results include: the prevalence of HCV infection in correctional setting is much greater than the prevalence in the general population; most correctional agencies are treating HVC infection using treatment procedures much like those used in the community; and the great cost of new medications make it very hard for correctional facilities to treat a substantial number of HCV infected inmates.